• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Jury selection for Elizabeth Holmes fraud trial begins today

Jury selection for Elizabeth Holmes fraud trial begins today

August 31, 2021 By Danielle Kirsh

Elizabeth Holmes Theranos
Former Theranos CEO Elizabeth Holmes leaves after a federal court hearing in San Jose, California, on July 17, 2019. [Photo by  Stephen Lam/Reuters]
Jury selection for ex-Theranos CEO Elizabeth Holmes’ federal fraud trial is set to begin today in U.S. District Court in San Jose, California.

Holmes faces 10 counts of wire fraud and two counts of conspiracy to commit wire fraud over allegations that she knowingly misled investors by claiming Theranos technology could revolutionize blood testing. She has pleaded not guilty to all charges.

The trial was originally slated to begin on October 27, 2020, but has been delayed because of the COVID-19 pandemic and then Holmes’ pregnancy announcement in March.

In the months leading up to the trial, the prosecution and defense have haggled with U.S. District Judge Edward Davila over the inclusion of evidence. Prosecuting attorneys want to present evidence that they say shows Holmes’ desire for recognition and wealth motivated her to lie about the capabilities of Theranos’ technology to detect disease through one drop of blood. Both sides have traded blame over the loss of a Theranos database that would have shown the level of inaccurate blood-testing results.

Holmes’ defense lawyers claimed a “mental disease” defense in September 2020 and in May 2021 wanted to present evidence about Silicon Valley startup culture.

More recently, court filings that were unsealed on August 28 suggest defense attorneys plan to defend Holmes by accusing Sunny Balwani — Theranos’ former president and chief operating officer, as well as Holmes’ former romantic partner — of emotional and psychological abuse, Reuters reports. Balwani has denied the allegations.

The assistant U.S. attorneys prosecuting the case filed a proposed witness list of nearly 280 people, CNN reports, including former Theranos board members Henry Kissinger and James Mattis. Also potentially facing the witness stand is Rupert Murdoch, who is among the company’s lengthy list of high-profile investors, which includes the family of late Walmart founder Sam Walton, former U.S. Education Secretary Betsy DeVos and her family, and many more.

Holmes and Theranos were once believed to be the next shining stars of Silicon Valley. Holmes claimed her company would revolutionize blood testing with technology that could analyze tiny amounts of blood and inked retail partnerships with Walgreens and Safeway. Forbes in 2015 recognized Holmes as America’s richest self-made woman based on Theranos’ multibillion-dollar valuation at the time.

Investigative reporting soon dismantled Holmes’ technological claims, raising questions about whether she and others misled investors. The downward spiral culminated in the 2018 shutdown of the company, with the U.S. Securities and Exchange Commission criminally charging Holmes and Balwani for what it described as a “massive fraud.”

Balwani’s trial is expected to follow the Holmes trial.

Filed Under: Featured, Legal News, News Well Tagged With: Elizabeth Holmes, Theranos

More recent news

  • Comphya raises CHF 7.5 million for neurostim to treat ED
  • Fujifilm launches intelligent automation features for digital radiography
  • Integer appoints former iRhythm CEO to board
  • MMI debuts robotic surgery instruments, digital surgery platform
  • Synchrony Medical wins FDA nod for airway clearance system

About Danielle Kirsh

Danielle Kirsh is an award-winning journalist and senior editor for Medical Design & Outsourcing, MassDevice, and Medical Tubing + Extrusion, and the founder of Women in Medtech and lead editor for Big 100. She received her bachelor's degree in broadcast journalism and mass communication from Norfolk State University and is pursuing her master's in global strategic communications at the University of Florida. You can connect with her on Twitter and LinkedIn, or email her at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy